T1	Limited_variation	54 79	mutations in promoter and
T2	Limited_variation	80 110	exon regions of eIF3a gene and
T3	Limited_variation	129 155	eIF3a mutation status have
T4	Chemical	198 235	platinum -based chemotherapeutic lung
T5	Disease	198 251	platinum -based chemotherapeutic lung cancer patients
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	isAssociatedWith	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	influences	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	influences	Arg1:T3	Arg2:T1
R10	influences	Arg1:T3	Arg2:T2
R11	influences	Arg1:T3	Arg2:T4
R12	influences	Arg1:T3	Arg2:T5
R13	isAssociatedWith	Arg1:T4	Arg2:T1
R14	isAssociatedWith	Arg1:T4	Arg2:T2
R15	isAssociatedWith	Arg1:T4	Arg2:T3
R16	treats	Arg1:T4	Arg2:T5
R17	isAssociatedWith	Arg1:T5	Arg2:T1
R18	isAssociatedWith	Arg1:T5	Arg2:T2
R19	isAssociatedWith	Arg1:T5	Arg2:T3
R20	treats	Arg1:T5	Arg2:T4
